Leap Therapeutics’ shares rose significantly by 25% after announcing a $58.9 million private investment from Winklevoss Capital to advance its crypto treasury strategy.
The investment will enable Leap to acquire cryptocurrencies and support drug development, with details of specific cryptocurrencies yet to be disclosed.
Leave a Reply